RDUS | Radius Health, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	18.55 - 19.58
52 Week Range	12.69 - 31.70
Beta	1.49
Implied Volatility	50.92%
IV Rank	31.65%
Day's Volume	123,396
Average Volume	191,451
Shares Outstanding	27,839,500
Market Cap	545,097,410
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2014-06-06

Valuation
Profitability
Growth
Health
P/E Ratio	-2.09
Forward P/E Ratio	N/A
EPS	-9.37
1YR Price Target	N/A
Dividend Yield	4.27%
Dividend Per Share	0.84
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	3,011
Country	USA
Website	RDUS

Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a transdermal system that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone-receptor positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts. As of August 10, 2022, Radius Health, Inc. was taken private.

RDUS's peers: FMTX, EWTX, EIGR, LIAN, ZYXI, CERC, AADI, TALS, PHAT, FLDM

*Chart delayed

Analyzing fundamentals for RDUS we got that it has weak fundamentals where Valuation is considered to be fairly valued, Profitability is unacceptably poor, Growth is good and Health is very weak. For more detailed analysis please see RDUS Fundamentals page.

Watching at RDUS technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on RDUS Technicals page.